Gara Jalqabaatti › Burkitt Lymphoma › Pennsylvania › Philadelphia
Qorannoo klinikaalii Burkitt Lymphoma Philadelphia, PA keessatti
Qorannoo 16 Burkitt Lymphoma f Philadelphia fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia
Namoota walitti qabaa jiraSadarkaa 3
- Children's Hospital of Philadelphia (Data Collection Only), Philadelphia
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
Namoota walitti qabaa jiraSadarkaa 1
- Children's Hospital of Philadelphia, Philadelphia
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Namoota walitti qabaa jiraSadarkaa 2
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · Miili 25 fagaatti
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Namoota walitti qabaa jiraSadarkaa 3
- University of Pennsylvania/Abramson Cancer Center, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
Blinatumomab Consolidation in Real World
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- University of Pennsylvania, Philadelphia
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Namoota walitti qabaa jiraQorannoo ilaalaa
- Children's Hospital of Philadelphia, Philadelphia
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Namoota walitti qabaa jiraSadarkaa 2
- Children's Hospital of Philadelphia, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · Miili 25 fagaatti
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Namoota walitti qabaa jiraSadarkaa 1/2
- Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Namoota walitti qabaa jiraSadarkaa 2
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · Miili 25 fagaatti
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Namoota walitti qabaa jiraSadarkaa 3
- Children's Hospital of Philadelphia, Philadelphia
- Saint Christopher's Hospital for Children, Philadelphia
- Alfred I duPont Hospital for Children, Wilmington · Miili 25 fagaatti
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Namoota walitti qabaa jiraSadarkaa 2
- Children's Hospital of Philadelphia, Philadelphia
CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT
Namoota walitti qabaa jira
- Children's Hospital of Philadelphia, Philadelphia
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
Namoota walitti qabaa jiraSadarkaa 1/2
- Children's Hospital of Philadelphia, Philadelphia
Co-administration of CART22-65s and huCART19 for B-ALL
Namoota walitti qabaa jiraSadarkaa 1/2
- Children's Hospital of Philadelphia, Philadelphia
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Namoota walitti qabaa jiraSadarkaa 1/2
- Children's Hospital of Philadelphia, Philadelphia
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
Namoota walitti qabaa jiraSadarkaa 2
- Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington · Miili 25 fagaatti
Qorannoo Burkitt Lymphoma magaalota biroo keessatti
- Houston, TXQorannoo 21
- Milwaukee, WIQorannoo 16
- Chicago, ILQorannoo 15
- Cincinnati, OHQorannoo 13
- New York City, NYQorannoo 13
- Atlanta, GAQorannoo 12
- Aurora, COQorannoo 11
- Seattle, WAQorannoo 11
- Durham, NCQorannoo 10
- Boston, MAQorannoo 10
- Kansas City, MOQorannoo 10
- Los Angeles, CAQorannoo 10
Qorannoo biroo Philadelphia keessatti
- Saree (Gosoota Hunda)Qorannoo 59
- Saree OljooQorannoo 56
- Kansara Qara'a Non-Small CellQorannoo 51
- Kansara MetastatikiiQorannoo 46
- Kansarii ProstateQorannoo 44
- Kansarii ColorectalQorannoo 44
- Kansarii OvariiQorannoo 44
- Dhibee QaraQorannoo 36
- Leukemia Myeloidii HamaaQorannoo 34
- Cufama OnneeQorannoo 31
- Kansa EndometiriyaaliiQorannoo 28
- DepreshiniiQorannoo 26
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.